SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000929638-23-002949
Filing Date
2023-10-31
Accepted
2023-10-31 18:01:27
Documents
2
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1378
2 exhibit24.htm EX-24 5464
  Complete submission text file 0000929638-23-002949.txt   8221
Mailing Address C/O ASPREVA PHARMACEUTICALS CORPORATION 1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8
Business Address
Glickman Richard M (Reporting) CIK: 0001352637 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41854 | Film No.: 231365992

Mailing Address 7171 RUE FREDERICK BANTING SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 RUE FREDERICK BANTING SAINT-LAURENT A8 H4S 1Z9 (514) 332-4888
enGene Holdings Inc. (Issuer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
SIC: 2836 Biological Products, (No Diagnostic Substances)